510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Sta Liatest D-DI

K141144510(k) TraditionalCleared Sep 3, 2014124-day reviewClass II21 CFR 864.7320Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Diagnostica Stago · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Cleared on Sep 3, 2014 as substantially equivalent to K964728 (American Bioproducts Co., 1997) and 1 other predicate after a 124-day review. Its family tree reaches back 4 generations to 1986. It has been recalled once.

Decided
Sep 3, 2014
Review
124 days
Class
Class II
Product code
DAP
Recalls
1
Predicates
2

Its longest line of descent runs back 4 generations to K862156 (1986). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK862156 Asserachrom D-DI KitAmerican Bioproducts Co. · 1986
  2. 3 generations backK973819 Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc. · 1998
  3. 2 generations backK020810 Vidas D-Dimer New (DD2) Assay Model#30 442bioMerieux, Inc. · 2002
  4. 1 generation backK040882 Vidas D-Dimer Exclusion Assay, Model 30 442bioMerieux, Inc. · 2004
  5. This deviceK141144 Sta Liatest D-DIDiagnostica Stago · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K862156Asserachrom D-DI KitAmerican Bioproducts Co.1986—
−3K973819Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc.1998—
−2K020810Vidas D-Dimer New (DD2) Assay Model#30 442bioMerieux, Inc.2002—
−1K040882Vidas D-Dimer Exclusion Assay, Model 30 442bioMerieux, Inc.2004—
0 (this device)K141144Sta Liatest D-DIDiagnostica Stago2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
FIG. 1 — Lineage of K141144, 1986–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DAP device

  1. #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964728Sta-Liatest D-DI Test Kit
Summary page 4
…II Panel: Hematology Product Code: DAP Regulation Number: 864.7320 Predicate Devices: STA® - Liatest® D-Di (K964728) VIDAS® D-Dimer ExclusionTM (K040882) Device Intended Use:  New Device Intended Use The STA®…
American Bioproducts Co.19971
*K040882Vidas D-Dimer Exclusion Assay, Model 30 442
Summary page 4
…DAP Regulation Number: 864.7320 Predicate Devices: STA® - Liatest® D-Di (K964728) VIDAS® D-Dimer ExclusionTM (K040882) Device Intended Use:  New Device Intended Use The STA® - Liatest® D-Di kit is an immuno-turbidimetric assay for the quant…
bioMerieux, Inc.2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 12, 2025Class IIZ-0205-2026Under Investigation by firmA potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 4 companies; a new generation was cleared every 10.2 years on median.
  • 1 of the 5 ancestors has a recall of any class.

How does its category compare?

All DAP devices

DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · DAP

1in 2017

2007: 22008: 32009: 12010: 22011: 12012: 12014: 12015: 12016: 22017: 12026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DAP

127in 2008

2008: 127 days median
2007high 127 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DAP

2in 2025

2015: 12021: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DAP

2in 2025

2007: 42008: 102009: 132010: 92011: 142012: 102013: 82014: 92015: 382016: 202017: 172018: 52019: 92020: 112021: 72022: 302023: 42024: 12025: 2
2007high 38 (2015) · low 1 (2024)2025

MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20083127010
20091—013
20102—09
20111—014
20121—010
20130—08
20141—09
20151—138
20162—020
20171—017
20180—05
20190—09
20200—011
20210—17
20220—030
20230—04
20240—01
20250—22
20261—0—

What is it indicated for?

The STA® - Liatest® D-Di kit is an immuno-turbidimetric assay for the quantitative determination of D-dimer in venous plasma (in 3.2% sodium citrate) for use on STA-R®, STA Compact® and STA Satellite® analyzers by professional laboratory personnel. The STA® - Liatest® D-Di is intended for use in conjunction with a clinical pretest probability (PTP) assessment model to exclude pulmonary embolism (PE) and as an aid in the diagnosis of deep venous thrombosis (DVT) in outpatients suspected of PE or DVT.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K141144: Sta Liatest D-DI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141144

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026